Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 284700011000036111 | cyanocobalamin + ferric pyrophosphate + lysine + pyridoxine + thiamine (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 428591000036119 | lysine + thiamine + pyridoxine + cyanocobalamin + ferric pyrophosphate | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| lysine + thiamine + pyridoxine + cyanocobalamin + ferric pyrophosphate | Is a | lysine | true | Inferred relationship | Some | ||
| lysine + thiamine + pyridoxine + cyanocobalamin + ferric pyrophosphate | Is a | pyridoxine | true | Inferred relationship | Some | ||
| lysine + thiamine + pyridoxine + cyanocobalamin + ferric pyrophosphate | has intended active ingredient | cyanocobalamin | true | Inferred relationship | Some | 1 | |
| lysine + thiamine + pyridoxine + cyanocobalamin + ferric pyrophosphate | has intended active ingredient | ferric pyrophosphate | true | Inferred relationship | Some | 2 | |
| lysine + thiamine + pyridoxine + cyanocobalamin + ferric pyrophosphate | has intended active ingredient | thiamine | true | Inferred relationship | Some | 3 | |
| lysine + thiamine + pyridoxine + cyanocobalamin + ferric pyrophosphate | has intended active ingredient | pyridoxine | true | Inferred relationship | Some | 4 | |
| lysine + thiamine + pyridoxine + cyanocobalamin + ferric pyrophosphate | has intended active ingredient | lysine | true | Inferred relationship | Some | 5 | |
| lysine + thiamine + pyridoxine + cyanocobalamin + ferric pyrophosphate | Is a | cyanocobalamin | true | Inferred relationship | Some | ||
| lysine + thiamine + pyridoxine + cyanocobalamin + ferric pyrophosphate | Is a | thiamine | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| lysine hydrochloride 150 mg/5 mL + thiamine hydrochloride 5 mg/5 mL + pyridoxine hydrochloride 2.5 mg/5 mL + cyanocobalamin 12.5 microgram/5 mL + iron (as ferric pyrophosphate) 5 mg/5 mL oral liquid | Is a | True | lysine + thiamine + pyridoxine + cyanocobalamin + ferric pyrophosphate | Inferred relationship | Some | |
| lysine hydrochloride 300 mg/10 mL + thiamine hydrochloride 10 mg/10 mL + pyridoxine hydrochloride 5 mg/10 mL + cyanocobalamin 25 microgram/10 mL + iron (as ferric pyrophosphate) 10 mg/10 mL oral liquid | Is a | True | lysine + thiamine + pyridoxine + cyanocobalamin + ferric pyrophosphate | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR